Melanie Homberg, PhD
Market Development Manager
at Lonza
Melanie Homberg studied Biology and performed her PhD and Postdoc research in the field of skin biology at the University of Leipzig. When joining Lonza in 2017, she supported customers using Nucleofector® Technology and primary cells as Product Support Specialist. She is now a global market development manager for Lonza’s Nucleofector® Platform with a focus on high throughput applications, e.g. CRISPR screenings.
Got a Question for Melanie Homberg, PhD?
Get in touch using the contact form linked here and we’ll get back to you shortly